Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosisElisa Rojas‐Prats, Ana Martı́nez, Eva de Lago et al.|European Journal of Medicinal Chemistry|2020Cited by 48
Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)Gabriela Liseth Vaca-Altamirano, Ángeles Martín‐Requero, Loreto Martínez‐González et al.|Journal of Neurochemistry|2020Cited by 30
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric NanoparticlesElisa Rojas‐Prats, Ana Martı́nez, Carlota Tosat‐Bitrián et al.|Pharmaceutics|2021Cited by 22
Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA NanoparticlesVanesa Nozal, Ana Martı́nez, Carmen Gil et al.|International Journal of Molecular Sciences|2021Cited by 22